S&P 500

5.431,60

-0,04%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NYSE
Meridian Gold (MDG)
Meridian Gold (MDG) Notícias

MDG

Meridian Gold (MDG)

Meridian Gold

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NYSE:MDG

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
27/01/2014	06:23	GlobeNewswire	Medigene acquires Trianta Immunotherapies	NYSE:MDG	Meridian Gold
27/01/2014	06:22	GlobeNewswire	Medigene übernimmt Trianta Immunotherapies	NYSE:MDG	Meridian Gold
18/12/2013	04:30	GlobeNewswire	Medigene's drug Veregen® launched in Norway and Sweden	NYSE:MDG	Meridian Gold
18/12/2013	04:30	GlobeNewswire	Medigenes Medikament Veregen® kommt in Norwegen und Schweden auf den Markt	NYSE:MDG	Meridian Gold
13/12/2013	04:30	GlobeNewswire	Medigene Granted Additional Patent for RhuDex® for the Treatment of Autoimmune Diseases	NYSE:MDG	Meridian Gold
13/12/2013	04:30	GlobeNewswire	Medigene erhält weiteres europäisches Patent für Autoimmun-Medikamentenkandidaten RhuDex®	NYSE:MDG	Meridian Gold
11/12/2013	04:30	GlobeNewswire	Medigene announces Veregen® to be launched in the Czech Republic, Poland, Hungary, and Slovakia	NYSE:MDG	Meridian Gold
11/12/2013	04:30	GlobeNewswire	Medigene kündigt Markteinführung von Veregen® in Tschechien, Polen, Ungarn und der Slowakei an	NYSE:MDG	Meridian Gold
05/12/2013	04:31	GlobeNewswire	Taurus becomes new marketing partner for Medigene's drug Veregen® in Germany	NYSE:MDG	Meridian Gold
05/12/2013	04:30	GlobeNewswire	Taurus wird neuer Partner für Medigenes Medikament Veregen® in Deutschland	NYSE:MDG	Meridian Gold
08/11/2013	04:30	GlobeNewswire	Medigene reports financial results for the first nine months of 2013	NYSE:MDG	Meridian Gold
08/11/2013	04:30	GlobeNewswire	Medigene veröffentlicht 9-Monats-Finanzbericht 2013	NYSE:MDG	Meridian Gold
01/10/2013	02:30	GlobeNewswire	Medigene announces market launch of Veregen® in Taiwan	NYSE:MDG	Meridian Gold
01/10/2013	02:30	GlobeNewswire	Medigene gibt Markteinführung von Veregen® in Taiwan bekannt	NYSE:MDG	Meridian Gold
10/09/2013	02:30	GlobeNewswire	Medigene's Drug Veregen® receives market approval in Canada	NYSE:MDG	Meridian Gold
10/09/2013	02:30	GlobeNewswire	Medigenes Medikament Veregen® erhält Zulassung für Kanada	NYSE:MDG	Meridian Gold
21/08/2013	02:31	GlobeNewswire	Medigene to implement 4:1 share capital reduction effective 3 September 2013	NYSE:MDG	Meridian Gold
21/08/2013	02:30	GlobeNewswire	Medigene vollzieht angekündigte 4:1 Kapitalherabsetzung mit Wirkung zum 3. September 2013	NYSE:MDG	Meridian Gold
09/08/2013	02:30	GlobeNewswire	Medigene veröffentlicht 6-Monats-Finanzbericht 2013	NYSE:MDG	Meridian Gold
09/08/2013	02:30	GlobeNewswire	Medigene reports financial results for the first 6 months of 2013	NYSE:MDG	Meridian Gold
06/08/2013	02:31	GlobeNewswire	Medigene and Difa Cooper enter into agreement for the commercialization of Veregen® in Italy	NYSE:MDG	Meridian Gold
06/08/2013	02:30	GlobeNewswire	Medigene und Difa Cooper vereinbaren Partnerschaft zur Vermarktung von Veregen® in Italien	NYSE:MDG	Meridian Gold
29/07/2013	02:30	GlobeNewswire	Medigene AG: Markteinführung von Veregen® in Niederlanden gestartet	NYSE:MDG	Meridian Gold
29/07/2013	02:30	GlobeNewswire	Medigene AG: Market launch of Veregen® in the Netherlands started	NYSE:MDG	Meridian Gold
17/07/2013	10:58	GlobeNewswire	Medigene Reports Outcome of Annual General Meeting	NYSE:MDG	Meridian Gold
17/07/2013	10:58	GlobeNewswire	Medigene berichtet über Ergebnisse der Hauptversammlung	NYSE:MDG	Meridian Gold
05/06/2013	03:03	GlobeNewswire	Medigene plant Herabsetzung des Grundkapitals sowie Verkleinerung und Neuwahl des Aufsichtsrats	NYSE:MDG	Meridian Gold
05/06/2013	03:03	GlobeNewswire	Medigene announces capital reduction and nomination of new members to a reduced Supervisory Board	NYSE:MDG	Meridian Gold
04/06/2013	03:00	GlobeNewswire	Medigene's drug Veregen® receives market authorization notification in Taiwan	NYSE:MDG	Meridian Gold
04/06/2013	03:00	GlobeNewswire	Medigenes Medikament Veregen® erhält Zulassung für Taiwan	NYSE:MDG	Meridian Gold